Company / Cost of Revenue
ENDRA Life Sciences Inc. Cost of Revenue History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
-
FY2020
5-year range
$0 / $172.8K
FY2017-FY2020
Trend
-
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $172,782 to $0 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0 | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $172.8K | +0.0% |
| FY2017 | $172.8K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026